Case File №
#VI-2026-0712
Xingtai Jiachuang Technology
Request Full Data Access to the VendorInvestigate database of peptide tests.
Exhibit I
Compounds on File
37 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | C Okay | 8 | 7.6 | 4.5 | 9.5 | 4 Jul 2025 |
| Tesamorelin | D Poor | 8 | 7.2 | 3.4 | 10.0 | 4 Nov 2025 |
| Tirzepatide | E Bad | 15 | 6.6 | 0.0 | 10.0 | 8 Jul 2025 |
| 1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 | X N/A | 2 | 7.2 | 6.6 | 7.9 | 24 May 2026 |
| 1-Testosterone Cypionate (DHB) Raw | X N/A | 2 | 6.2 | 5.3 | 7.2 | 21 May 2026 |
| ACE-031 | X N/A | 3 | 5.2 | 4.1 | 7.2 | 20 May 2026 |
| BAC Water | X N/A | 1 | 4.0 | 3.9 | 3.9 | 21 May 2025 |
| BAM15 | X N/A | 1 | 6.8 | 6.8 | 6.8 | 13 Jun 2025 |
| BPC157 10mg + TB500 10mg Blend | X N/A | 3 | 6.1 | 4.9 | 7.3 | 19 Jan 2026 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 3 | 7.5 | 6.4 | 8.6 | 21 May 2026 |
| CJC-1295 With DAC | X N/A | 1 | 6.0 | 6.0 | 6.0 | 25 Apr 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 2 | 6.2 | 5.8 | 6.7 | 21 May 2026 |
| Clomid | X N/A | 1 | 8.9 | 8.9 | 8.9 | 21 May 2025 |
| Epithalon | X N/A | 1 | 9.5 | 9.5 | 9.5 | 13 Feb 2025 |
| FOXO4 | X N/A | 1 | 6.8 | 6.8 | 6.8 | 27 Feb 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 9.3 | 9.3 | 9.3 | 8 Jul 2025 |
| GW-501516 (Cardarine) | X N/A | 1 | 7.8 | 7.8 | 7.8 | 8 Jul 2025 |
| Healthy Hair Skin Nails Blend (Niacinamide+Thiamine+Pantothenic Acid+Choline+Inositol+Niacin+Biotin+Folic Acid+Riboflavin) | X N/A | 1 | 6.8 | 6.8 | 6.8 | 13 Feb 2025 |
| Hyaluronic acid | X N/A | 1 | 8.5 | 8.5 | 8.5 | 6 May 2025 |
| KPV Oral | X N/A | 3 | 8.6 | 7.9 | 9.8 | 21 May 2026 |
| MOTS-C | X N/A | 1 | 7.3 | 7.3 | 7.3 | 20 Jun 2025 |
| NA Semax Amidate | X N/A | 1 | 7.1 | 7.1 | 7.1 | 6 May 2025 |
| Ovagen | X N/A | 3 | 6.4 | 4.5 | 7.9 | 24 May 2026 |
| Pancragen | X N/A | 3 | 6.7 | 5.5 | 8.3 | 24 May 2026 |
| PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | X N/A | 1 | 5.1 | 5.1 | 5.1 | 21 May 2025 |
| Prednisone | X N/A | 3 | 7.2 | 5.9 | 8.6 | 20 May 2026 |
| Propionyl chloride CAS 79-03-8 | X N/A | 1 | 6.3 | 6.3 | 6.3 | 17 Dec 2024 |
| PTD-DBM | X N/A | 1 | 7.9 | 7.9 | 7.9 | 3 Jun 2025 |
| Retatrutide 5mg + Cagrilintide 5mg Blend | X N/A | 1 | 7.6 | 7.6 | 7.6 | 9 Jun 2025 |
| Retatrutide Raw | X N/A | 2 | 7.1 | 6.9 | 7.2 | 25 May 2026 |
| RIPEX 225 (TRA/Mast P/Test P) | X N/A | 3 | 6.7 | 5.9 | 7.7 | 19 Jan 2026 |
| Sildenafil Raw | X N/A | 1 | 8.3 | 8.3 | 8.3 | 2 Apr 2025 |
| SNAP-8 | X N/A | 3 | 6.1 | 5.1 | 6.9 | 26 Jan 2026 |
| T3 (Liothyronine) | X N/A | 1 | 6.5 | 6.5 | 6.5 | 13 Feb 2025 |
| Tadalafil Raw | X N/A | 1 | 6.3 | 6.3 | 6.3 | 16 Mar 2025 |
| Telmisartan | X N/A | 1 | 8.7 | 8.7 | 8.7 | 3 Jun 2025 |
| Winstrol Oil | X N/A | 2 | 4.9 | 4.6 | 5.3 | 24 May 2026 |
Exhibit II
Evidence Log
64 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | ACE-031 | 5.8 B | 50mg | 52.6mg | +5.3% | 99.40% | cmpg68 | Lab B | Public |
| 25 May 2026 | Clomid | 9.3 A | 25mg | 28.4mg | +13.4% | 98.64% | 4075h5 | Lab D | Public |
| 25 May 2026 | KPV Oral | 8.5 A | 25mg | 26.8mg | +7.1% | 95.30% | wupoj9 | Lab G | Community |
| 24 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 7.0 A | 50mg | 49.2mg | -1.7% | 96.80% | pwpg5k | Lab E | Community |
| 24 May 2026 | Hyaluronic acid | 9.1 A | 50mg | 59.7mg | +19.3% | 97.85% | ny1k70 | Lab G | Community |
| 24 May 2026 | Propionyl chloride CAS 79-03-8 | 7.8 A | 500g | 467.9g | -6.4% | 98.16% | fhs6bu | Lab F | Public |
| 24 May 2026 | Tirzepatide | 7.6 A | 30mg | 28.2mg | -6.0% | 99.89% | (no batch ID) | Lab E | Public |
| 24 May 2026 | Winstrol Oil | 5.1 B | 200mg/ml | 181.4mg/ml | -9.3% | 97.76% | ca5w9m | Lab E | Public |
| 24 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 6.2 A | 15mg | 13.1mg | -12.4% | 95.42% | 5ivk1i | Lab F | Public |
| 23 May 2026 | Tirzepatide | 8.0 A | 5mg | 5.14mg | +2.8% | 99.90% | (no batch ID) | Lab E | Public |
| 23 May 2026 | FOXO4 | 6.7 A | 5mg | 4.4mg | -11.8% | 97.88% | g3ldlm | Lab F | Community |
| 23 May 2026 | Pancragen | 8.7 A | 5mg | 4.9mg | -2.3% | 95.56% | w7m15v | Lab E | Public |
| 23 May 2026 | Retatrutide Raw | 6.3 A | 1g | 0.9g | -13.3% | 97.10% | uu8raw | Lab E | Community |
| 23 May 2026 | Tirzepatide | 8.0 A | 20mg | 21mg | +5.0% | 99.90% | (no batch ID) | Lab E | Public |
| 23 May 2026 | BPC157 10mg + TB500 10mg Blend | 4.7 C | 30mg | 30.3mg | +1.1% | 98.36% | vkt7wk | Lab B | Public |
| 23 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 7.3 A | 10mg | 12.1mg | +21.2% | 96.32% | 2zm3wa | Lab B | Community |
| 23 May 2026 | Pancragen | 5.7 B | 2mg | 2.0mg | +1.9% | 95.58% | 90q985 | Lab F | Public |
| 21 May 2026 | Tesamorelin | 7.8 A | 10mg | 10.6mg | +6.0% | 99.06% | 7Apr25 | Lab E | Public |
| 21 May 2026 | BAM15 | 8.3 A | 20mg | 24.6mg | +23.0% | 95.16% | tu09b8 | Lab C | Community |
| 21 May 2026 | KPV Oral | 10.0 A | 50mg | 51.4mg | +2.7% | 95.73% | 3sy6gn | Lab F | Public |
| 21 May 2026 | Tirzepatide | 8.6 A | 10mg | 10.7mg | +7.0% | 99.62% | Dec. 2, 2025 | Lab E | Public |
| 21 May 2026 | Tirzepatide | 7.3 A | 15mg | 15.2mg | +1.3% | 99.61% | (no batch ID) | Lab E | Public |
| 21 May 2026 | Ovagen | 8.9 A | 15mg | 12.8mg | -14.5% | 95.43% | vwq8k9 | Lab A | Community |
| 21 May 2026 | SNAP-8 | 4.7 C | 20mg | 22.6mg | +12.8% | 99.98% | 67eygv | Lab F | Public |
| 20 May 2026 | BPC157 10mg + TB500 10mg Blend | 6.4 A | 10mg | 10.9mg | +8.5% | 99.50% | scylxq | Lab E | Community |
| 20 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 4.9 C | 10mg | 11.6mg | +16.5% | 98.64% | b8r7gw | Lab B | Community |
| 20 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 6.0 A | 15mg | 15.3mg | +2.2% | 98.03% | xjqazb | Lab F | Public |
| 20 May 2026 | Prednisone | 10.0 A | 25mg | 31.0mg | +24.2% | 99.32% | bw8p8z | Lab E | Public |
| 20 May 2026 | RIPEX 225 (TRA/Mast P/Test P) | 5.5 B | 250mg/ml | 220.0mg/ml | -12.0% | 97.14% | r4j4zp | Lab D | Public |
| 19 May 2026 | 1-Testosterone Cypionate (DHB) Raw | 5.0 B | 5g | 4.3g | -14.2% | 99.59% | 88qdjr | Lab E | Public |
| 19 May 2026 | MOTS-C | 6.7 A | 10mg | 12.2mg | +22.1% | 95.70% | 8wpn04 | Lab C | Community |
| 19 May 2026 | Tesamorelin | 7.2 A | 10mg | 11.1mg | +11.0% | 99.49% | Tesa 11/20/2025 | Lab E | Public |
| 17 May 2026 | KPV Oral | 7.9 A | 25mg | 30.5mg | +22.0% | 98.08% | 1qduvh | Lab E | Community |
| 17 May 2026 | Retatrutide 5mg + Cagrilintide 5mg Blend | 7.6 A | 10mg | 10.8mg | +8.5% | 99.48% | jvoalk | Lab B | Community |
| 29 Jan 2026 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 4.4 C | 10g | 12.2g | +21.6% | 96.17% | i9v5jm | Lab A | Public |
| 26 Jan 2026 | CJC-1295 With DAC | 6.7 A | 15mg | 13.0mg | -13.1% | 99.75% | wd2jic | Lab A | Community |
| 26 Jan 2026 | Ovagen | 7.3 A | 10mg | 9.3mg | -6.7% | 97.25% | q72mev | Lab F | Public |
| 26 Jan 2026 | Winstrol Oil | 4.7 C | 300mg/ml | 293.9mg/ml | -2.0% | 97.32% | cqnmx3 | Lab A | Public |
| 19 Jan 2026 | BAC Water | 4.0 C | 5mg | 4.4mg | -12.7% | 97.65% | jrx19n | Lab G | Public |
| 19 Jan 2026 | GW-501516 (Cardarine) | 8.3 A | 20mg | 18.8mg | -6.0% | 96.09% | v9v0v3 | Lab B | Public |
| 19 Jan 2026 | Pancragen | 7.6 A | 30mg | 37.4mg | +24.5% | 96.74% | 7bh2b3 | Lab B | Public |
| 19 Jan 2026 | RIPEX 225 (TRA/Mast P/Test P) | 6.7 A | 250mg/ml | 269.0mg/ml | +7.6% | 97.51% | 34zzyg | Lab A | Community |
| 19 Jan 2026 | RIPEX 225 (TRA/Mast P/Test P) | 7.6 A | 200mg/ml | 230.4mg/ml | +15.2% | 98.02% | qijn3y | Lab G | Public |
| 9 Jan 2026 | Prednisone | 6.0 A | 100mg | 122.7mg | +22.7% | 98.91% | 1s6dmc | Lab B | Public |
| 6 Jan 2026 | PTD-DBM | 8.1 A | 10mg | 9.1mg | -9.4% | 99.03% | 5gfohu | Lab A | Public |
| 29 Dec 2025 | 1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 | 7.2 A | 500g | 522.9g | +4.6% | 96.28% | df63ot | Lab A | Community |
| 29 Dec 2025 | 1-Testosterone Cypionate (DHB) Raw | 7.3 A | 10g | 8.9g | -11.2% | 96.29% | hbdz6m | Lab C | Community |
| 12 Dec 2025 | 1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 | 6.6 A | 500g | 607.1g | +21.4% | 96.52% | oc55dq | Lab A | Community |
| 12 Dec 2025 | Ovagen | 7.1 A | 50mg | 62.1mg | +24.2% | 96.31% | 4k4b3f | Lab D | Public |
| 23 Nov 2025 | ACE-031 | 6.0 A | 30mg | 31.9mg | +6.5% | 96.94% | s4e2zs | Lab C | Community |
| 23 Nov 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 6.9 A | 10mg | 8.6mg | -14.4% | 95.18% | 8ff4df | Lab G | Community |
| 17 Nov 2025 | ACE-031 | 4.0 C | 30mg | 36.4mg | +21.4% | 98.38% | 1kk66d | Lab G | Public |
| 14 Nov 2025 | Epithalon | 8.9 A | 15mg | 13.7mg | -8.4% | 98.04% | aohz5f | Lab A | Public |
| 14 Nov 2025 | Retatrutide Raw | 8.5 A | 1g | 1.1g | +13.4% | 98.38% | qwra9j | Lab F | Public |
| 14 Nov 2025 | SNAP-8 | 5.9 B | 5mg | 5.2mg | +3.1% | 96.15% | zf7m65 | Lab E | Community |
| 5 Nov 2025 | SNAP-8 | 4.1 C | 10mg | 9.1mg | -8.6% | 95.46% | pkefj3 | Lab A | Community |
| 5 Nov 2025 | Tadalafil Raw | 6.7 A | 100g | 87.8g | -12.2% | 96.62% | avfuib | Lab G | Public |
| 4 Nov 2025 | BPC157 10mg + TB500 10mg Blend | 5.1 B | 2mg | 2.2mg | +8.6% | 95.43% | nt04ir | Lab A | Community |
| 4 Nov 2025 | Sildenafil Raw | 9.7 A | 5g | 6.1g | +22.9% | 99.72% | nv687v | Lab A | Community |
| 9 Oct 2025 | T3 (Liothyronine) | 6.3 A | 50mg | 61.1mg | +22.3% | 96.43% | 3y2uow | Lab B | Community |
| 9 Oct 2025 | Telmisartan | 8.2 A | 10mg | 12.4mg | +23.8% | 95.36% | 88iw28 | Lab F | Public |
| 3 Oct 2025 | Healthy Hair Skin Nails Blend (Niacinamide+Thiamine+Pantothenic Acid+Choline+Inositol+Niacin+Biotin+Folic Acid+Riboflavin) | 6.0 A | 100mg/ml | 110.5mg/ml | +10.5% | 97.27% | e8jhlg | Lab E | Community |
| 3 Oct 2025 | NA Semax Amidate | 6.9 A | 2mg | 2.2mg | +8.2% | 98.43% | cx7kks | Lab C | Public |
| 3 Oct 2025 | Prednisone | 5.5 B | 100mg | 100.8mg | +0.8% | 98.87% | i774bw | Lab B | Public |